U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07267169) titled 'Efferon LPS Hemoadsorption in Patients With Acute Pancreatitis' on Nov. 25.
Brief Summary: The goal of the study is to evaluate the safety and efficacy of multimodal (cytokine and lipopolysaccharide) hemoperfusion using the Efferon(R) LPS device in combination with hemofiltration (HF) / hemodiafiltration (HDF), with the goal of reducing the severity of organ dysfunction (measured by SOFA score) in patients with acute pancreatitis.
Participants will be assigned to two groups for comparison: a control group receiving baseline therapy with HF/HDF, and a treatment group receiving baseline therapy in combination with HF/HDF and Efferon(R...